New Trends in Opioids and Pain Management
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
3 MIN READ
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.
Out-of-Network Dispensing Channels and Their Unique Challenges
11 MIN READ
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dive deeper into part two of our annual drug trends series. In this short video they will discuss aggregate trends and challenges within our combined in- and out-of-network channels to address the total view of prescription activity.
Top 3 Retail and Mail Order Trends
10 MIN READ
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our annual drug trends series. In this short video they’ll discuss standout trends from our most recent retail and mail order data focusing on decreasing opioid trends and significant jumps in migraine and respiratory medications.
Ask The Pharmacist: Marijuana and Controlled Substance Classifications
3 MIN READ
Recently, the U.S. Department of Justice (DOJ) proposed rescheduling marijuana from a Schedule I to a Schedule III controlled substance. This change follows a review requested by President Biden in 2022 and supported by medical and legal evaluations from the Department of Health and Human Services (HHS) and the Justice Department’s Office of Legal Counsel (OLC). The rulemaking process will include public notice, comments and an administrative hearing before any final decision is made.
Enlyte Quarterly Medical Price Index - Q2
5 MIN READ
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the consumer price index in the United States increased 3.4% over the preceding 12 months. The medical care index rose 0.4% in April 2024 after rising 0.5% in March 2024. The index for hospital services increased 0.6% over the month and the index for physician’s services increased 0.1% which would be compared to Enlyte’s data in this report.
Enlyte Pharmacists Discuss a Changing Workers’ Comp Pharmacy Landscape
4 MIN READ
Workers' compensation pharmacy is constantly evolving, from tackling the opioid crisis, to the rise of compounding pharmacies, to the pandemic. Amidst these changes, pharmacy benefit managers must constantly evolve to address an array of industry changes. In our final Enlytening Conversation our pharmacists discuss how changes within the industry as a whole including physician shortages, digital therapeutics, biopsychosocial approaches, new drug treatments, and much more are driving the need for constant planning and innovation to stay a step ahead in this ever-changing landscape.